Zealand Pharma Inches Higher on Positive Phase 1 Obesity Drug Data

(PLX AI) – Zealand Pharma shares rose 1.2 percent after positive early data on phase 1 trial of its BI 456906 obesity drug candidate. Patients involved in the study saw greater bodyweight reduction than placebo, with no unexpected safety issues, …